Subscribe free

HPB & Spleen ·

Impact of Ideal Outcome on Survival After Pancreatic Surgery

Achieving an ideal outcome (io) after pancreatoduodenectomy for resectable pancreatic head cancer significantly improves overall survival and treatment continuity.

  • In patients achieving io, the 5-year overall survival was 74.7% versus 46.0% for those who did not (p=0.011).
  • io achievement led to 86.1% initiating adjuvant chemotherapy compared to 67.2% in the non-io group, with earlier initiation (postoperative day 44 vs. 56; p<0.001).
  • Longer post-recurrence survival was noted in the io group (median 15 months vs. 6 months; p=0.009).

These findings underscore the importance of optimizing perioperative outcomes to enhance long-term survival in patients undergoing surgery for pancreatic cancer.

Journal Article by Aso K, Yoshioka R (…) Saiura A et 7 al. in Ann Surg Oncol

© 2026. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

HPB & Spleen13 Nov 2026

Robotic Whipple Procedure Moves Toward Routine Use

Robotic pancreatoduodenectomy has matured past its experimental phase, and randomized trials support it as a safe alternative to open surgery. Its results still depend on surgeon experience and institutional volume.

All papers in HPB & Spleen →